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Abstract
Background: Asthma is a genetically heterogeneous disease. Polymorphisms of genes encoding components of
the vitamin D pathway have been reported to associate with the risk of asthma. We have previously demonstrated
that vitamin D status was associated with lung function in Chinese asthma patients. In this study, we tested
whether polymorphisms of genes encoding for vitamin D receptor (VDR), vitamin D 25-hydroxylase (CYP2R1) and
vitamin D binding protein (GC) were associated with asthma in the Chinese Han population.
Methods: We sequenced all 8 exons of VDR and all 5 exons of CYP2R1 in a Chinese case-control cohort of asthma
consisting of 467 cases and 288 unrelated healthy controls. Two mutations were identified in these regions. These
variants were specified as rs2228570 in exon 2 of VDR and rs12794714 in exon 1 of CYP2R1. We also genotyped
two common polymorphisms in GC gene (rs4588 and rs7041) by a PCR-restriction fragment length polymorphism
(RFLP) method. We analyzed the association between these 4 polymorphisms and asthma susceptibility and
asthma-related traits.
Results: Polymorphic markers in VDR and CYP2R1 were not associated with asthma in the Chinese Han cohort.
Importantly, variants in GC gene, which give rise to the two most common electrophoretic isoforms of the vitamin
D binding protein, were associated with asthma susceptibility. Compared with isoform Gc1, Gc2 was significantly
associated with the risk of asthma (OR = 1.35, 95% CI = 1.01-1.78 p = 0.006).
Conclusions: The results provide supporting evidence for association between GC variants and asthma
susceptibility in the Chinese Han population.
Background
Asthma is a chronic inflammatory disease of the airways
characterized by reversible airflow obstruction and air-
way hyper-reactivity. The disease exhibits complex pat-
terns of transmission, and has an estimated heritability
of 36 - 79% [1]. To date, a plethora of genes and var-
iants have been implicated in the pathogenesis and pro-
gression of asthma [2,3]. However, relatively few of
these genes and variants have been successfully
replicated.
In recent years the vitamin D pathway has emerged as
a new potential component of asthma and allergy sus-
ceptibility. The majority of this evidence has been
derived from epidemiological surveys. Deficiency of vita-
min D has been found to increase the risk of asthma or
asthma exacerbation [4-8]; higher maternal vitamin D
intake during pregnancy has been associated with a
reduced risk of wheezing illnesses in young children
[9-11]; and circulating 25-hydroxyvitamin D (25OHD)
has been associated with lung function in patients with
asthma [7,12,13]. More recently, a small randomized
double-blinded 6 month trial indicated that vitamin D
supplementation in children may reduce asthma exacer-
bation following acute respiratory infection [14].
At the genetic level, a number of polymorphisms have
been identified in various components of the vitamin D
pathway; including the vitamin D receptor VDR,t h e
* Correspondence: y.zhang@imperial.ac.uk; gaojm@pumch.cn
1Department of Respiratory Diseases, Peking Union Medical College Hospital,
Peking Union Medical College & Chinese Academy of Medical Sciences,
Beijing 100730, China
2Molecular Genetics and Genomics, National Heart and Lung Institute,
Imperial College London, London, UK
Full list of author information is available at the end of the article
Li et al. BMC Medical Genetics 2011, 12:103
http://www.biomedcentral.com/1471-2350/12/103
© 2011 Li et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.microsomal vitamin D hydroxylase CYP2R1,a n dt h e
vitamin D binding protein GC. VDR is the major recep-
tor for the bioactive form of 25OHD, 1a,25-dihydroxyvi-
tamin D3 (1,25OHD). The gene encoding VDR is
located on human chromosome 12q13 and has 8 coding
exons encode 427 amino acids. CYP2R1, positioned on
human chromosome 11p15, is responsible for trans-
forming photo-synthesized and dietary vitamin D into
25OHD [15]. CYP2R1 g e n eh a s5e x o n se n c o d i n g5 0 1
amino acids. Vitamin D metabolites in the circulation
are bound to vitamin D binding protein (DBP) encoded
b yah i g h l yp o l y m o r p h i cg e n eGC. GC is located on
chromosome 4q13 and has 13 exons encoding 474
amino acids. There are two common functional single
nucleotide polymorphisms (SNPs) in exon 11 of GC,
which are rs4588 and rs7041 positioned at codons 416
and 420. These variants have been associated with dif-
ferent binding affinity for 25OHD, and give rise to the
two most common electrophoretic isoforms of DBP;
Gc1 (which can be further subdivided into Gc1F and
Gc1S); and Gc2. Whilst GC isoforms have been impli-
cated in chronic obstructive pulmonary disease (COPD)
across a variety of contrasting population (for review,
see reference 16), there is relatively little evidence of
their involvement in asthma [16,17]. VDR variants have
been extensively studied in asthma, although the results
have shown contradictory [15,18-23]. Similarly, evidence
for association between CYP2R1 variants and asthma
has also been inconsistent between populations [15].
One potential explanation for this inconsistency may be
differences in the underlying pattern of linkage disequili-
b r i u mb e t w e e nt y p e dm a r k e r sa n dt h et r u ed i s e a s el o c i
in distinct populations.
We previously showed that lower vitamin D status in
serum was associated with impaired lung function in
Chinese asthma patients [12]. In this study we set out to
evaluate whether the variants of genes encoding for the
key components of vitamin D pathway, including
CYP2R1, VDR, and DBP, were associated with asthma
or asthma-related phenotypes in a case-control design
study in the Chinese Han population.
Methods
Subjects and phenotypical characteristics
We recruited 467 asthma patients and 288 controls with
Han ethnicity from the Northern region of China. All
participants were unrelated. Asthma cases were
recruited at the Pulmonary Clinic, Peking Union Medi-
cal College Hospital. Ethnicity-matched controls were
selected from non-asthmatic, non-atopic, healthy indivi-
duals with normal lung function [24].
Measurement of serum total IgE was performed by
applying the UniCAP System (Pharmacia, Uppsala, Swe-
den) according to the manufacturer’s instructions.
Asthma was diagnosed using the criteria defined by
international guideline [25]. All cases complained of cur-
rent asthma symptoms including wheezing, cough, awa-
kening at night and shortness of breath. Asthmatics
with forced expiratory volume in 1s (FEV1) ≥ l70% of
predicted underwent the methacholine challenge test,
and positive bronchial hyperresponsiveness was defined
by a 20% fall in FEV1 at inhaled methacholine concen-
trations ≤16 mg/ml. Patients with FEV1 < 70% of pre-
dicted underwent an airway reversibility test with
positive airway reversibility defined by both 12%
improvement in FEV1 and an increase ≥ 200 ml in the
absolute FEV1 value after b2-agonist inhalation [25].
The incidence of asthma was higher in females than in
males (60.4% vs 39.6%). The baseline FEV1%p r e d i c t e d
was significantly lower in asthmatics than normal con-
trols (68.9 ± 37.9% vs 90.6 ± 14.9%, P < 0.001). Metha-
choline airway challenge test was performed in 224
(48%) asthma subjects with baseline FEV1> 70% of pre-
dicted; in all of these subjects, positive bronchial hyper-
responsiveness was documented. The airway reversibility
test was carried out in 273 patients (58%). The mean
improvement in FEV1 was 26.4 ± 14.3%. The serum
total IgE values in controls were within the normal
range. Detailed characteristics of the individuals are
listed in Table 1.
The study protocol was reviewed and approved by the
Human Research Ethics Committee of the Peking Union
Medical College Hospital, and all subjects gave written
informed consent to participate in the study.
SNPs selection and genotyping
DNA samples (derived from 467 asthma patients and
288 healthy, non-atopic controls) were extracted from
peripheral blood leukocytes using a standard phenol-
chloroform method.
All selected genes code for key enzymes or compo-
nents responsible for vitamin D metabolic pathway. Sin-
gle nucleotide polymorphisms (SNPs) of genes tested in
this study have been associated with asthma
Table 1 Demographics of the participants
Asthma (n = 467) Control (n = 288)
Mean age, years 40.8 ± 14.1 45.1 ± 0.7
Range 18-76 22-72
Sex, n (%)
Male 185 (39.6) 158 (55.0)
Female 282 (60.4) 130 (45.0)
logeIgE, U/L 5.24 ± 1.44 3.64 ± 1.10
Eosinophils,% 1.63 ± 0.91 2.19 ± 0.93
Lung function
FEV1,% 68.94 ± 37.88 90.6 ± 14.92
FEV1/FVC,% 63.93 ± 14.91 81.53 ± 9.52
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VDR and CYP2R1 in all 755 individuals and identified
two mutations, specified as rs2228570 in exon 2 of VDR
a n dr s 1 2 7 9 4 7 1 4i ne x o n1o fCYP2R1. Sequencing VDR
and CYP2R1 genes was performed at the Beijing Geno-
mics Institute (http://www.genomics.cn). DNAStar 5.0
SeqMan Software was used to identify DNA variants
and provide genotype calls. The primers for PCR were
designed by using Primer Premier 5.0 Software.
Sequences of the primers are listed in Table 2.
We genotyped the two most commonly studied SNPs
in the GC gene, rs4588 and rs7041, using a standard
PCR-restriction fragment length polymorphism (PCR-
RFLP). Genetic variants in GC gene have been shown
the different affinity in binding vitamin D metabolites
[26]. The SNPs rs4588 and rs7041 have been found to
have associations with several chronic lung diseases,
such as COPD and tuberculosis [27,28]. Carriage of
the genotype of Gc2 allele was associated with
increased tuberculin-stimulated IFN-g release in Gujar-
ati Asian TB contacts [27]. Homozygous carriers of the
rs7041 T allele exhibited an increased risk for COPD
i naB e l g i u mp o p u l a t i o n[ 2 8 ] .T h e r ea r eo n l y1 1b a s e
pairs apart between these two SNPs in the human gen-
ome, however, they are not in the same LD block.
Thus we selected these two important SNPs in our
Chinese samples to test the association with the risk of
developing asthma. These two SNPs, rs4588 and
rs7041, are positioned at codons 416 (GAT®GAG,
Asp®Glu) and 420 (ACG®AAG, Thr®Lys) of exon
11 of the GC gene (Table 3) [27]. The different loci
were recognized by the following restriction
Table 2 Primer sequences and PCR conditions for genotyping VDR, CYP2R1 and GC variants
Gene Region PCR primers(5’®3’) Sequencing primer(5’®3’) Annealing
temperature(°C)
PCR
product
(bp)
Restriction
Enzyme
RFLP
products
(bp)
VDR
Exon 1 F:TGGCACCAAGGATGCCAGCT 57 364
R:TCCTGCTCCTGTGGCTGTGA R:GTGAGCGCCGCATGTTCC
Exon 2 F:CCTCATGTCTTCTGTTGGAG F:CCTCATGTCTTCTGTTGGAG 57 438
R:TGCATCTGACCCTGGACTTC
Exons
3,4
F: CCTATCTTGGACCTTTACCC F: CCTATCTTGGACCTTTACCC 57 758
R:TCCATTAGGGAGCCTTCCAC
Exon 5 F: CTGTGGAGTCACTGTGGGAT F: CTGTGGAGTCACTGTGGGAT 57 390
R:GAAGTGGTGGATGAGTGATC
Exons
6,7
F: TGTTGGTGCCCAGCAGGTGT F: TGTTGGTGCCCAGCAGGTGT 57 680
R:GCTACGTCTCCCTTCAGGTT
Exon 8 F: TGCTGCCGTTGAGTGTCTGT 57 526
R:GGTTGGACAGGAGAGAGAAT R:
ACAGGAGAGAGAATGGGCTG
CYP2R1
Exon 1 F:GGGACCTGAGGGTATCCTGC F:
ACCTGAGGGTATCCTGCCAATG
55 409
R:GGCGGCCATAAGTCCAACC
Exon 2 F: AGGGACGTAACAAATCCTGG F: AGAGCCGCACTTACCACTTG 57 412
R: GTAGTACAGCCTGAAAGGTC
Exon 3 F: AACAGGACCCAACCATGTAG F:
GGAGGACAATTTGGAGAAGG
57 881
R: CATCGCAGGAGTTCCTAAAG
Exon 4 F: TGGCTTGTTATAGGTTATCC 57 574
R: CATTCTCTCCTGTTAGAATC R: CATTCTCTCCTGTTAGAATC
Exon 5 F: GTTCTGCTTGCTGAAGTGTC F: CATAGTTCCCTCTTTCTTTG 57 415
R: ACCAAGTTCAGGGATAAGGC
GC
rs4588
rs7041
F:
AAATAATGAGCAAATGAAAGAAGAC
55 483 Hae III 297/186
R:
CAATAACAGCAAAGAAATGAGTAGA
Sty I 305/178
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at 37°C, Sty I for C/A at 37°C.
The PCR reactions were performed in a total volume
of 30 μl( 4 0u lf o rGC variants genotyping) containing
70 ng of genomic DNA, 3 μlo f1 0×P C RB u f f e r ,1 . 5
μMo fM g C l 2, 0.17 mM of dNTPs, 100 pM of each pri-
mer, and 1.5 U of Taq DNA polymerase (Takara). In
general, PCR cycle condition consisted of an initial
denaturation step at 94°C for 3 min followed by 30
cycles (35 cycles for GC variants genotyping) of dena-
turation for 30 s at 94°C, annealing for 30 s at 55-57°C,
extension for 40- 45 s at 72°C, and a final extension at
72°C for 7 min.
Statistical analysis
Because of similar functional characteristics of GC iso-
forms Gc1F and Gc1S, allele carriers were combined to
produce a total of 3 genotypes: Gc1/1, Gc1/2 and Gc2/
2. Allele and genotype frequencies of polymorphisms in
VDR, CYP2R1 and GC were obtained by direct counting,
and Hardy-Weinberg equilibrium was evaluated by a
chi-squared test (using SPSS statistical software, version
12.0). All genotype and phenotype data were formatted
using PLINK.
Quantitative traits were tested using a variance com-
ponents approach implemented in the statistical package
Merlin [29]. Quantile normalization was applied to all
quantitative traits prior to analysis (with the exception
of total serum IgE which had already been subjected to
a log transformation). Missing genotypes were inferred
using the — infer option available in Merlin.
In addition, an unpaired t-test was used to compare
the baseline data between asthma patients and healthy
controls. One-way ANONA was used to assess the gen-
otype distribution in asthma patients. A Bonferroni cor-
rection was used to adjust p-values for multiple testing
(based on an alpha threshold of 0.05). Genotype and
allele frequencies in cases and controls were also com-
pared by contingency table analysis. Genotype relative
risk was calculated according to the statistical method
described by Lathrop [30]. This method compares case
genotype frequencies with expected control genotype
frequencies under the assumption of Hardy-Weinberg
equilibrium, and is more powerful than standard contin-
gency table analysis.
Results
We genotyped 1 SNP (rs12794714) in CYP2R1,1S N P
(rs2228570) in VDR, and 2 SNPs (rs4588 and rs7041) in
GC. The allele and genotype frequencies are listed in
Table 4. All SNPs met criteria for Hardy-Weinberg
equilibrium in both case and control groups (all p-value
> 0.05).
No significant difference was observed in the genotype
and allele frequencies of rs2228570 in VDR and
rs12794714 in CYP2R1 between asthmatic cases and
controls (Table 4), suggesting that these SNPs were not
genetically associated with the risk of asthma.
Importantly, single marker analysis of association
showed that GC polymorphism (expressed as Gc1/1,
Gc1/2 and Gc2/2) was significantly associated with
asthma susceptibility in our Chinese samples, the risk
conferred by it was slightly elevated (OR = 1.35, 95% CI
= 1.01 - 1.78, P = 0.006). Compared with Gc1/1 geno-
type, Gc2/2 genotype was strongly associated with the
risk of asthma (OR = 13.13, 95% CI = 2.42-7.13, P =
0.001) (Table 4). These results may suggest that Gc2/2
genotype confers a significant risk for developing
asthma.
Vitamin D deficiency has been defined as serum
25OHD < 50 nmol/l [31]. We have previously demon-
strated that vitamin D deficiency is common among Chi-
nese patients with asthma [12]. Thus, we retrospectively
analysed the association between the GC polymorphisms
and serum 25-OHD concentrations, however, no signifi-
cant difference was observed (Table 5).
We further examined the evidence for association
between the polymorphic markers in these three genes
and a number of quantitative asthma-related traits using
Merlin. We were not able to demonstrate any significant
associations between the studied SNPs and blood eosin-
phil counts, log-transformed serum IgE or lung function
Table 3 Deduction of vitamin D binding protein genotypes from Haelll and Styl genotypes [27]
Haelll/Styl
Genotypes
Potential
haplotypes
Deduced haplotypes Corresponding DBP genotypes Asthma (N) Control
(N)
HH SS HS/HS HS/HS Gc1F/Gc1F 72 41
HH Ss HS/Hs HS/Hs Gc1F/Gc2 129 59
HH ss Hs/Hs Hs/Hs Gc2/Gc2 24 1
Hh SS HS/hS HS/hS Gc1F/Gc1S 93 46
Hh Ss Hs/hS or HS/hs* Hs/hS Gc2/Gc1S 71 35
hh/SS hS/hS hS/hS Gc1S/Gc1S 27 18
Hh/Ss hS/hs* Gc1s/not deduced Not assigned 0 0
*frequency of the hs haplotype is very low due to linkage disequlibrum between loci
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shown).
Discussion
We performed a case-control study assessing association
between polymorphisms in 3 genes of the vitamin D
pathway and asthma susceptibility in the Chinese Han
population. We showed that the GC polymorphisms giv-
ing rise to the major electrophoretic isoforms of vitamin
E binding protein (rs4588 and rs7041) were significantly
associated with the risk of asthma, although not 25OHD
concentrations in asthma patients. By sequencing all
exons of VDR and CYP2R1 genes, we have identified
that the full range of exonic genetic variants presented
in our cohort have shown allele frequencies ≥0.13%. We
observed only two exonic SNPs, rs2228570 (also known
as Fok I) in VDR and rs12794714 in CYP2R1,b o t ho f
which had been previously characterised. No association
could be identified between either of these SNPs and
asthma. Because exonic regions are more likely to carry
variants that disrupt protein function [32,33], our poly-
morphism screening did not include intronic or promo-
ter regions of these genes which may also potentially
contain causal variants [34].
The FokI polymorphism in exon 2 of VDR consists of
a T to C change which has been reported to cause
gene-specific and cell type-specific effects. VDR poly-
morphisms have been widely studied in asthma, and the
results have been contradictory [15,18-23]. The associa-
tion of polymorphisms in VDR with asthma was first
reported in Northern American family-based studies
[19,20], but initial positive results were not replicated in
subsequent populations [22,23]. Consistent with our
negative results, a previous case-control study of
rs2228570 performed in a Chinese Han population also
failed to show an association with asthma [21].
The CYP2R1 variant, rs12794714, has previously been
associated with serum 25OHD levels in a healthy Cauca-
sian population [35]. Alternative CYP2R1 variants have
also been implicated in asthma susceptibility, though
these effects have not replicated consistently among
populations [15]. This lack of consistency may reflect a
linkage disequilibrium phenomenon (with non-coding
Table 4 Association between asthma and polymorphisms of CYP2R1, VDR, GC genes
Genotype/Allele Asthmatics,
n (%)
Controls, n (%) c
2 P
VDR rs2228570
CC 152 60
CT 230 91
TT 85 37 0.194 0.908
C 534 (57.2) 211 (56.1)
T 400 (42.8) 165 (43.9) 0.122 0.727
CYP2R1 rs12794717
CC 171 64
CT 214 86
TT 81 25 1.02 0.601
C 556 (59.7) 214 (61.1)
T 376 (40.3) 136 (38.9) 0.234 0.628
GC
Gc1/1 192 105
Gc1/2 200 94
Gc2/2 24 1 10.401 0.006
Gc1 584 (70.2) 304 (76.0)
Gc2 248 (29.8) 96 (24.0) 4.527 0.033
Table 5 Frequency of genotypes of CYP2R1, VDR, DBP in
asthmatics with different vitamin D status
Serum 25OHD Subjects, n Genotypes, n (%) P value
CYP2R1 rs12794717
CC CT TT
≥50 nmo l/L 49 20 (40.8) 24 (49) 5 (10.2)
< 50 nmol/L 363 132(36.4) 167 (46) 64 (17.6) 0.42
VDR rs2228570
CC CT TT
≥50 nmol/L 49 13 (26.5) 25 (51.1) 11 (22.4)
< 50 nmol/L 362 124 (34.3) 180 (49.7) 58 (16) 0.397
GC rs4588 and rs7041
Gc1/1 Gc1/2 Gc2/2
≥50 nmol/L 49 20 (40.8) 26 (53.1) 3 (6.1)
< 50 nmol/L 363 169 (46.5) 173 (47.7) 21 (5.8) 0.747
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fined gene-gene (epistatic) or gene-environment interac-
tions, or a low magnitude effect requiring large, highly
powered cohorts for its detection.
The vitamin D binding protein (DBP), encoded by
GC, is the principle plasma carrier protein of vitamin
D and its metabolites. Due to a higher binding affinity
of Gc1F and Gc1S to 25OHD, the isoforms are
hypothesized to deliver 25OHD to target tissues more
efficiently than Gc2 [26]. The results presented here
indicate that the two common SNPs in GC which
determine DBP isoforms associate significantly with
susceptibility to asthma, and that the Gc1 allele might
confer a protective effect. One previous study of GC
variants in asthma did not find an association, how-
ever, this study included a very small number of parti-
cipants and was probably underpowered to detect a
difference [17].
Polymorphisms in GC gene have been found to be
significantly associated with 25OHD concentrations by
genome-wide association (GWA) [36,37]. We have
previously shown that lower serum 25OHD concentra-
tions are associated with impaired lung function mea-
surements in Chinese patients with asthma [12]. In
this study, we reported the association between
genetic variants in GC and asthma susceptibility.
Thus, we further investigated the influence of GC gen-
otypes on serum 25-OHD concentrations in asthma
patients. When performing multiple tests for the asso-
ciation analysis with Bonferroni correction to the
dataset, we couldn’t find any significant association.
One explanation could be that circulating serum
25OHD concentrations are influenced by several
genetic loci [36,37].
Conclusion
In conclusion, this study has shown that genetic variants
in the gene encoding the vitamin D binding protein
(GC) contribute to asthma susceptibility in a Han Chi-
nese population. The OR in this study with respect to
Gc2/2 homozygote suggests a modest but definite
genetic effect. We have not found associations between
that exonic variants in the VDR and CYP2R1genes and
asthma or asthma-related traits in our Chinese popula-
tion. Further research is needed to understand how
gene-gene or gene-environment interactions and causa-
tive regulatory variants (intronic, promoter, or trans-act-
ing) influence vitamin D metabolism in asthma patients
[34].
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